Adams HP, Adams RJ, Brott T (2003 ): Guidelines for the early
management of patients with ischemic stro ke: A scientific statement from the Stroke Co uncil of the American Stroke Association. Stroke 34:
1056 – 1083
Albers GW , Hart RG, Lutsep HL (199 9): AHA Scientific Statement.
Supplement to the guide line s for the management of transient ischemic attacks: A stateme nt from the Ad Hoc Committee on Guid elines for the Management of Transient Ischemic Attacks, Stroke Cou ncil, Ame rican Heart Association. Stroke 30: 2502 - 2 511
Albers GW , Amarenco P, Easton JD (2004): Antith rombo tic and Thrombolytic Therapy for Ischemic Stroke. The Seventh ACCP
Conference on Antithrombotic und Thrombolytic Therap y. Chest 126:
483 - 512
American Heart Association (2004 ): Heart Disease and Stroke Statistics 2004 update .(www. heart.org)
Asplund K, Britton M (1989 ); Eth ics of life support in patients with se vere stro ke. Stro ke 20, 1107 – 1112
Astrup J, Sie sjo BK, Symon L (1981): Thresholds in ce re bal ischemia - the ischemic penu mbra. Stro ke 12, 7 23 - 725
Astudillo R, van de r Linden J, Rade gran K, Hansson L O, Aberg B (1996): Ele vated serum le ve ls of S -10 0 after deep hypoth ermic a rre st correlate with duration of circulato ry a rrest. Eu r J Ca rdiothorac Su rg 10, 1107 - 1113
Aurell A, Rosen gre n LE, Karlsson B, Olsson JE, Zbo rnikova V, Ha glid K (1991): Dete rmination of S100 and GFA protein concentrations in
cerebro spina l fluid after brain infarctio n. Stroke 22, 1254 - 1258 Barber PA, Zhan g J, Demchuk AM (20 01): W hy are stroke patients
excluded from TPA therap y? An ana lysis of patient e ligib ility. Neuro lo gy 56: 1015 - 1020
Baudier J, Gla sse r N, Ge rad D (1986): Ions bind ing to S1 00 proteins. II.
Conformational stu dies and ca lcium -in duced conformational chan ges in S100 alpha prote in : the effect of acidic pH and ca lcium incubation on subunit e xchange in S100a (alpha beta) prote in. J Bio l Chem 261, 8192 - 8203
Berger K, Schu lte H, Sto gbaue r F, Assmann G (1998 ): Incidence and risk factors for stro ke in an o ccup ational coho rt: the PROCAM Study. Pro spective Card io vascula r Mu enster Stud y. Stroke 29 (8), 1562 - 1566
Bertsch T, Casa rin W , Kretschmar M, Zimmer W , W alter S, Sommer C, Mueh lhause r F , Rago schke A (2001 ): Protein S -100B: a serum marker for ischemic and infectious injury of cereb r al tissue. Clin Chem Lab Med 39(4 ), 31 9 – 323
Bitsch A, Ho rn C, Kemmling Y, Seipe lt M, He llenb rand U, Stiefel M, Ciesiellczyk B, Cep ek L, Bahn E, Ra tzka P, Pran ge H, Otto M (2002):
serum tau prote in levl as a ma rke r of axona l damage in a cute ischemic stroke. Eur J Neu ro l 47(1 ), 45 - 51
Boysen G, Brott T, Orgo go zo JM (199 2): Stroke score s a nd scales.
Cereb ro vasc Dis 2, 239 - 247
Brott T, Adams HP, Olin ge r CP (1989 ): Measu rement of acute cerb ra l infarction: a clinica l e xamination sca le . Stroke 20, 864 – 870
Brott T, Bo goussla vsky J (2000): Trea tment of acute isch emic stroke.
N En gl J Med 34 3 (10), 710 - 722
Büttner T, W eyers S, Postert T, Spren gelme ye r R, Kuhn W (1997): S -100 protein: serum marker of focal bra in damage after ischemic territo ria l MCA infarction. Stroke 28, 1 961 - 1965
Butterwo rth RJ, W assif W S, Sherwood RA, Ge rges A, Po yser KH,
Garth wa ite J, et al (1996): Se rum neuron -specific enola se, carnosinase, and their ratio in a cute stroke: an en zymatic test for pred icting
outcome? Stroke 2 7:2064 – 2068
Butterwo rth RJ, Sh erwood RA, Bath PM (1998 ): Se rum S -100-p rotein in acute stroke. Stroke 29(3), 730
Castellanos M, Se rena J (2007 ): Applicability of Biomarkers in Ischem ic Stroke. Cereb ro va sc Dis 24 (1), 7 – 15
Castillo J, Le ira R, García MM, Serena J, Blan co M, Dá va los A (2004 ):
Blood pressure de crease durin g the a cute phase of ische mic stroke is associa ted with bra in in jury and poor stroke outcome. Stroke 35:
520 - 526
Collins R, Peto R, MacMahon S, He bert P, Fiebach NH, Eberle in KA, God win J, Qizilba sh N, Ta ylo r, JO, Henne kens CH (1990 ): Blood pressu re, stroke, a nd coronary heart disease . Pa rt 2, Sh ortterm
reductions in b lood pressu re: o ve rvie w of randomised drug tria ls in the ir epidemiolo gical co ntext. Lancet 335 (8693), 827 - 838
Coull BM, Ma lino w MR, Beame r N, Se xton G, No rdt F, de Garmo P (1990): Ele vated p lasma homocyst( e )ine concentration a s a possible independent risk factor for stroke. Stroke 21, 572 - 576
Cunnin gham RT, Young IS, W inder J, Okane MJ, Mc Kin stry S, Johnston CF, Do la n OM, Ha wkins SA, Buchanan KD (199 1): Serum neuron specific en olase le vels as an indicat or of neuronal damage in patients with cereb ral infarction . Eur J Clin In ve st 32, 497 - 500
Daffertshofer M, Mielke O, Pu llwitt A (2004): Transient ischemic attacks are more than "min istrokes". Stroke 3 5(11): 2453 - 2458
Da vis SM, Donnan GA, Butcher KS, Parsons M (2005): Selection of thrombolytic be yon d 3 h usin g ma gneticresonance imagin g. Curr Op in Neuro l 18: 47 - 52
Diene r HC, Brain in M, Mattle H (2004): Aktuelle Lite ratu r zu r Pathoph y-siolo gie, Dia gnostik, Proh yla xe und T herapie von Schla ganfällen.
Stroke -Ne ws 9 (3), 19
Dirna gl U, Iadeco la C, Mosko witz MA (1999): Pathobio lo gy of ischemic stroke: an inte grate d vie w. Trends Neu rosci 22, 391 - 397
Dobkin BH (2005): Clinical p ractice. Rehabilitation after stroke. N En gl J Med 352 (16 ), 1 677 - 1684
Dorndo rf W , Hornig C (1985 ): Proble me der Klassifizierung ischäm i-scher zereb ro vasku läre r Insu lte. Nerve narzt 56, 169 - 173
Drier JK, Swanson PE, Cherwitz DL et al (1987 ): S100 p rotein immunoreactivity in poorly differentiated carcinomas.
Immunohistochem ical comparison with maligna nt melano ma.Arch Pathol Lab Med 11, 447 - 452
Eisenblatter D, Heinemann L, Cla ssen E (1995 ): Com munitybased stroke incidence trends from the 1970s throu gh the 1980 s in East German y. Stroke 2 6 (6), 919 - 923
Fassbender K, Sch midt R, Schre iner A, Fatar M, Mühlha user F, Daffertshofer M, Hennerici M (1997 ): Leakage of brain -o riginated proteins in pe riphe ral blood: tempora l profile and dia gnostic va lue in early ischemic stro ke. J Neuro l Sci 14 8 (1), 101 - 105
Fiebach JB, Sche llinger PD, Gass A (2 004 a): Stro ke magnetic
resonance imagin g is accurate in h ype racute intra cereb ra l hemorrha ge:
a multicente r stud y on the validity of stroke imagin g. Stro ke 35, 502 - 506
Fiebach JB, Sche llinger PD, Geletneky K (2004 b): MRI in acute subarachno id haemorrha ge; findin gs with a standa rdised stroke protocol. Neu rorad iology 46: 44 - 48
Fink JN, Selim MH, Kumar S, Silve r B, Linfante I, Caplan LR, Sch laug G (2002): Is the asso ciation of National Institute s of Health Stroke Scale Scores and cute magnetic resonance imagin g stroke vo lu me equal for patients with right and left-hemisphere ischemic stroke? Stroke 33:
954 - 958
Foerch C, Sin ger OC, Neumann -Haefelin T, du Mesnil de Rochemont R, Steinmetz H, Sitzer M (2005): Evaluation of serum S100B as a
surroga te marke r for lon g -term outco me and infarct volu me in acute middle ce rebra l artery infarction. Arch Neuro l 62(7 ), 1130 – 1134
Gass A, Röther J, Gaa J (1999 ): Diffusion an perfusion -weighted MRI in cerebra l ischemica – Part 2: Clinical applications. Akt Neurol 26,
309 – 317
Ginsbe rg MD, Pu lsinelli W A(1994): The ischemic penumbra, in jury
threshold s, and the therapeutic windo w for acute stroke. Ann Neuro l 36, 553 - 554
Gruener N, Gross B, Go zlan O, Bara k M (1994): In crea se in supe ro xide dismutase after ce rebro vascu la r accid ent. Life Sci 54:711 - 713
Gupta R, Connolly ES, Ma ye r S (2004 ): Hem icraniectom y for massive middle ce rebra l artery te rrito ry infarction: a systematic re vie w. Stro ke 35(2): 539 - 543
Hacke W , Brott T, Caplan L (1999): T hrombolysis in acute ischemic stroke: controlled tria ls and clinica l e xperience. Neu rolo gy 53: 3 - 14 Hacke W , Donnan G, Fie schi C (2004 ):Asso ciation of outcome with early stroke treatment: Pooled analysis of atlantis, e cass, and ninds rt -pa stroke trials. La ncet 363: 768 - 774
Hacke W , Markku K, Bluhmki E, Bro zman M et al (2008): Thrombolysis with Altepla se 3 to 4,5 Hours after Acu te Ischemic Stro ke. N En gl J Med 359, 1317 - 1329
Harde r T, Gerke V (1993): The subce llular d istrubition of early
endosomes is affected by the anne xinII2p11 (2) comple x. J Ce ll Biol 123, 1119 – 1123
Hartmann A,(1983): Die med ikamentöse Behandlun g des Hirnödems.
Nervena rzt 54, 277 - 293
Häussler B: Risikofaktoren des Schla ganfalls. In: Diene r H, Mau ritz K.:
Der Schla ganfall. Georg Thieme Verlag, Stuttga rt 1996, 23 - 29
Heiland S, Sa rtor K (1999): Ma gnetic resonance tomogra phy in stroke – its methodolo gica l bases and clin ical use. Röfo 171, 3 - 14
Heizmann CW , Hunziger W (1991): Intracellu lar calcium -binding proteins: more site s than insights. Tre nds Biochem Sci 1 6, 98 - 103 Herrmann M, Eh ren reich H (2003): Bra in derived p rotein s as marke rs of acute stroke: Their relation to pathoph ysio lo gy, outcome prediction and neuroprotective d ru g monito rin g. Restor Neu rol Neu rosci 21, 177 - 190 Herrmann M, Vo s P, W underlich M, de B ruijn C, Lamers K (2000):
Release of glial tissue -specific p roteins after acute stroke. Stroke 31, 2670 - 2677
Hill MD, Jacko wski G, Ba yer N, La wre nce M, Jaeschke R (2000):
Biochemica l markers in acute ischemic stroke. CMAJ 162 :1139 - 1140 Hoffman E: Der Sto ffwechse l. Dynam ische Biochemie Teil III .: Akade -mie Verl,Berlin 198 4,17
Hofmeijer J, van de r W orp HB, Kapelle LJ (2003 ): Treatm ent of space -occup yin g cereb ral infarction. Crit Ca re Med 31(2 ), 617 - 625
Hu J., Ferreira A, Van eldik L J, (1997): S100beta induces neuronal ce ll death throu gh nitric oxide release from astrocytes. J Neu rochem 69(6), 2294 - 2301
Ingeb rigtsen T, Ro mner B (1996 ): Serial S -100 prote in serum
measurement related to early magnetic resonan ce ima gin g after head inju ry. J Neu rosu rg 85, 945 - 948
Isobe T, Ichimura T , Oku yama T (1989 ): Chemestry and cell b iolo gy of neuron-and gliaspe cific p roteins. Arch Histol Cyto l 52, 25 - 32 Suppl.
James FT, Ma lino w MR, Chambless L E, Spence JD ( 200 4): Lo we rin g homocysteine in pa tients with ischemic stroke to p re vent recu rrent stroke, m yocard ial infarction and death: the vitamin inte rvention for stroke p re vention (VISP) r andomized contro lled tria l. JAMA 291, 565 - 575
Jansen O, Heiland S, Schellin ge r P (1 998): Neu rorad ioligical dia gnosis in acute ischemic str oke. Va lue of modern technique s . Nervena rzt 69, 465 - 471
Jauch EC, L indse ll C, Brode rick J, Fa gan SC, Tille y BC, L evine SR (2006): Association of Serial Biochemical Markers W ith Acute Ischemic Stroke The Nationa l Institute of Neuro logical Disorde rs an d Stroke Recombinant Tissu e Plasmino gen Activato r Stroke Stud y. Stroke 37, 2508 - 2513
Johnsson P, Lund qvist C, L ind gren A, Ferebcz U, Allin g C, Stahl E (1995) : Ce rebra l complica tions afte r ca rdiac su rge ry assessed b y S100 and NSE in b lood. J Ca riotho rac Vasc Anaesth 9, 1 - 7
Kato K, Kimura S (1985): S100ao protein is mainly lo cate d in the heart and striated muscles. Biochem Bioph ys Acta 842 (2-3 ), 1 46 - 150
Kiechl S, Traind l O ( 2003): Prä ven tio n des Schla ganfa lls. W ien Med W ochenschr 153 (1 -2), 6 -13
Kim JS, Yoon SS, Kim YH, Ryu JS (1 996): Serial measurements of interleukin -6, transforming d roth factor- and protein S -100 in patients with a cute stroke. Stroke 27, 1553 - 1 557
Kimura S, Kato K, Sema R, Isobe T (1 984): Re gional d istribution of S100ao, S100a and S100b in the bo vine nervous tissue determined with a sensitive en zyme immunoassa y system. Neurochem Int 6, 513 - 518 Kindblom LG, Lodd ing P, Ro sen gren L , Baudier J, Haglik K (1984):
S100 protein in melanocytic tumors. Acta Pathol Microb io l Immunol Scand 92, 219 - 23 0
Klatzko I (1985 ): Brain oedema follo wing b rain ischem ia and the Influence o f therapy. Br J Anaesth 57, 18 - 22
König W (2003): Global card io va scula r risk assessment: impro vin g strate gies in patien ts at inte rmediate risk. Int J Pract 137 , 34 - 43, Suppl.
Kogu re K, Kato H: Neurochemistry of stroke. In: Ba rnett HJM, Moh r JP, Stein BM, Yatsu FM: Stroke, pathoph ysio lo gy, d ia gnosis an
management. Churchill L ivin gstone, Ne w York 1992, 69 - 101 Kolominsky-Rabas P L, Sarti C, He uschmann PU, Graf C,
Siemonsen S, Neundoerfer B, Kata lin ic A, Lang E, Gassmann KG, von Stocke rt TR (1998): A pro spective communitybased stud y of
stroke in Ge rman y the Erlan gen Stroke Proje ct (ESPro ): inci dence and case fatality at 1, 3 , and 12 months. Stroke 29 (12), 2501 – 2506
Krie ge r D, Adams HP, Rieke K (1993 ): Monito rin g therap eutic efficacy of decompressive craniotom y in space occup ying ce rebellar infarcts usin g bra in -stem a uditory e voked potentials. Ele ctroencephalogr Clin Neuroph ysio l 88, 261 - 270
Mahone y FI, Barth el DW (1965): Functional e va luation: The Barthel Index. Md Sta te Me d J 14, 61 - 65
Malino w MR, Bosto m AG, Krauss RM (1999): Homocyst(e )ine, Die t, and Card io vascula r Diseas es A Statement for Healthca re Professiona ls From the Nu trition Committee, American Heart Association. Circu lation 99,178 - 182
Marler JR (1995 ): For the n inds -stud y group: Tissue p lasminogen activato r for acute ischemic stro ke. N Engl J Med 333: 1 581 - 1587.
Masuhr KF, Neumann M : Neu ro logie. 5. Auflage, Thieme Verla g Stu t t-ga rt 2004
Mergentha ler P, Dirnagl G, Me ise l A (2004):Pathoph ysiology of stroke.
Lessons from anim al models. Metab Brain Dis 19(3 -4 ), 15 1 – 167
Missle r U, W iesmann M, Friedrich C, Kaps M (1997): S -1 00 protein and neuron-spe cific en olase concentratio ns in b lood as ind icators of
infarction volume a nd pro gnosis in a cute ischemic stroke . Stroke 28, 1956 - 1960
Mohr JP, Biller J, Hila l SK, Yuh W T, Ta temichi TK, Hed ges S, Tali E, Ngu yen H et al (19 95): Ma gnetic reso nance versus comp uted
tomograph ic imagin g in acute stro ke. Stroke 26, 807 - 812
Moore BW (1965): A soluble prote in characte ristic of the nervous system. Biochem Bioph ys Res Commun 19, 739 - 744
Moulin T, Cattin Ft, Crep in -Leb lond T, Tatu L, Cha vot D, Piotin M, Viel JF, Rumbach L, Bo nneville JF (1996 ): Early CT signs in a cute middle cerebra l a rtery infarction: pred ictive value subse quent in farct locations and outcome. Neurology 47, 366 - 375
Naess H, W aje -Andreassen U, Thomassen L (2006 ): Mon itorin g in acute cerebra l infarction. Tidsskr. No r Lae geforen 126(4): 444 - 446
Nationa l Institute o f N eurolo gical Diso rder and Stroke rt -PA Stroke Study Group (1995 ): Tissue plasm inogen activato r for a cute stro ke. N Engl J Med 333, 15 81 - 1587
Neumann-Haefelin T, Kastrup A, de Crespign yA, Yena ri MA, Rin ge r T, Sun GH, Mosele y ME (2000 ): Se ria l MRI after transient focal cereb ral ischemia in rats d ynamics of tissue in jury, b lood -b rain ba rrier damage, and edema formation. Stroke 31, 196 5 - 1973
Noppe M, Crols R, Andries D, Lo wenth al A (1986 ): Determination in human cerebrosp in al fluid of glia l fibrillary acid ic p rote in, S -100 and myelin basic p rot e in as indices of non -specific or specific centra l nervous tissue pathology. Clin Ch im Acta 155(2 ), 143 - 150
Oh SH, Lee JG, Na SJ, Park JH, Choi YC, Kim W J (2003): Prediction of early clin ical se ve rity and e xtent of neuronal dama ge in a nterio r
-circulatio n infarctio n usin g the initial serum neuron -specif ic enola se le vel. Arch Neu rol 60:37 - 41
Persson L, Ha rdemark HG, Gustafsson J, Rundstrom G, Mendel Hartvig I, Essche r T, Pahlmann S (1987): S -1 00 protein and neu ron -specific enolase in cereb ro spinal flu id and se rum: markers of cell damage in human central ne rvous system. Stroke 18, 911 - 918
Raabe A, Seifert V, (1999): Fatal seco ndary increa se in serum A -100B protein after se vere haed inju ry. Rep ort of three case s. J Neu rosurg 91, 875 - 877
Rankin g J (1957 ): Cereb ral vascu lar accidents in patients o ver the a ge of 60, II: progno sis. Scott Med J 2, 20 0 - 215
Re ynold s MA, Kirchick HJ, Dahlen JR, Anderberg JM, McPherson PH, Nakamura KK, La sko witz DT, Valkirs GE, Buechle r KF (2 003): Early biomakers of stroke. Clin Chem 49 (1 0): 1733 - 1739
Roberts HC, Dillon W P, Furlan AJ, W echsle r LR, Ro wle y HA, Fischbe in NJ, Higash ida RT, Kas e C, Schulz GA , Lu Y, Firs t CM (2 002):
Computed tomogra phic findin gs in patients undergo in g intra -a rte ria l thrombolysis for a cute ischemic stroke due to middle ce re bral a rte ry occlusion. Stroke 3 3: 1557 - 1567
Robinson K, Arhea rt K, Refsum H, Brattström L, Boe rs G, Ueland P (1998): Lo w Circu latin g Fo late and Vitamin B6 Concentrations Risk Factors for Stroke, Periphe ral Va scula r Disea se , and Co ronary Artery Disea se. Circula tio n 97, 437 - 443
Röther J, Gass A, Busch E (1999): Diffusion and perfusion -we ighted MRI in ce reb ral ischemia – Part 1: Results of animal experiments. Akt Neuro l 26, 300 - 30 8
Röther J, Sche llin ger PD, Gass A (200 2): Effect of intrave nous
thrombolysis on MRI paramete rs and functional outcome in acute stro ke
< 6 hours. Stroke 3 3(10): 2438 - 2445
Rosamond W , Flegal K, Frida y G, Furie K, Go A (2007 ): Heart d isease and stroke statistics: a repo rt from the A merican Heart Association Statistics Committe e and Stroke Statistics Subcomittee. Circulation 115, 69 - 171
Save r J (2006 ): Time is bra in -quantified. Stroke 37: 263 - 266 Schäfer BW , Heizmann CW (1996): The S100 family of EF -hand clcium-b indin g p roteins : functions and patholoh y. Trends Biochem Sci 21(4), 134 - 140
Schlau g G, Benefie ld BS, Baird AE, Sie wert B, Lö vblad KO, Parke r RA, Edelman RR, W arach S (1999 ): The ischemic penumbra Operationa lly defined by diffusio n and perfusion MRI . Neuro lo gy 53, 15 28
Shimizu A, Su zuki F, Kato K (1983): Charakte risa tion of , , and
human enolase isoen zymes and pre paration of h ybrid e nolasis ( ,
, ) from homodimeric forms. Bio chem Biophys Acta 748, 278 - 284 Siesjö BK (1984 ): Cereb ral circu latio n and m etabolism. J Neu rosurg 60, 883 - 908
Sindic CJ, Cha lon MP, Camb iaso CL , Laterre EC, Masso n PL (1982):
Assessment of damage to the centra l n ervous system b y d etermination of S-100 protein in the cereb rospina l fluid. J Neuro l Neu ro surg
Psych iatry 45, 113 0 – 1135
Statistische s Bund esamt Deutsch land (2001): Deutsche Todes -ursachenstatistik 2 001, (www.de statis.de)
Sugimu ra K, Haimo to H,Na gu ra H, Kato K, Takahashi A. (1989):
Immunohistochemical differential distribution of S -100 a lpha and S -100 beta in the pe riphe ral ne rvous system of the rat. Muscle Nerve . 11, 929 - 935
Summer MM, Ozde mir I, Tascila r N (2 003): Pred icto rs of outcome after acute ischemic stro ke. Acta Neuro l Scand 107(4): 276 - 2 80
Suzu ki F, Umeda Y, Kato K (1983 ): Ra t brain eno lase iso enzyme s.
Purification of thre e forms of enolase. J Biochem 87, 158 7 - 1594
Taylo r TN, Da vis P H, Torner J C,Ho lmes J, Me yer J W , Jacobson M F (1996): L ifetime co st of stroke in the United State s . Stro ke 27 (9 ),
1459 - 1466
Tourdias T, Dousse t V, Sibon I, P e le E, Mene gon P, Asselineau J, Pachai C, Rouanet F, Rob inson P, Che ne G (2007): Ma gn etization
transfer ima gin g sh o ws tissue abno rmalities in the re versible penumbra.
Stroke 38 (12), 3165 - 3171
Usui A, Kato K, Ab e T, Murase M, Tan aka M Takeuch i E (1989) : S100 a0 protein in blood and urine du rin g op en heart su rgery. Clin Chem 35, 1942 - 1944
Vanstapel MJ, Gatter KC, de W olf Peeters C et a l (1986 ): Ne w site s of human S100 immunoreactivity detected with monoclonal antibodies. Am J Clin Patho l 85,16 0 - 168
W ald DS, La w M, Morris JK (2002): Homocyste ine and cardio vascu lar disease: e vidence on ca usality from a meta -analysis . BMJ 325, 1202 W all SD, Brant -Zawad zki M, Jeffrey RB, Barne s B (1982): High
frequen zy CT findings within 24 hou rs after cerebra l infarction. AJR 138, 307 - 311
W aterloo K, Ingeb rigsten T, Romner B (1997): Neurop sychologica l function in patients with increased serum le vels of p rotein S-100 after minor head in jury. Acta Neu rochir 139 , 26 - 32
W eih M, Mu lle rNo rdhorn J, Amberger N, Ma suhr F, Lurtzing F, Dre ier JP, Hetze l A (2004): Risk factors in ischemic stroke. Re vie w of evidence in p rim ary p re vention.Ne rvena rzt 75 (4 ), 324 - 335
W idman R, Miya za wa T, Hossmann KA (1993): Prote ctive effects of hypothe rmia on h ip pocampal inju ry after 30 minutes of focal b rain ischemia in rats is medicated b y postischemic reco ve ry of protein synthesis. J Neu ro chem 61, 200 - 209
W illmot M, Leonardi -Bee J, Bath P (20 04):High Blood p re ssure in acute stroke and subse qu ent outcome. Hype rtension 43: 18 - 24
W old F: The Enzym es. Volume 1. : Aca demic press, Ne w Yo rk 1971, 499 - 538
W underlich MT, Eb ert AT, Kratz T, Görtle r M, Jo st ST, Herr mann M (1999): The early n eurobeha vio ral outcome after stroke is re lated to the release of neurob io chemical ma rke rs o f brain damage. Stroke 30,
1190 – 1195
Zimmer DB, Co rn wall EH, Landar A, Song W (1995): The S100 protein family: Histo ry, function and e x p ressio n. Brain Res Bu ll 3 7(4), 417 - 429